Drug Shortage Report for JANUMET XR
| Report ID | 157337 |
| Drug Identification Number | 02416808 |
| Brand name | JANUMET XR |
| Common or Proper name | sitagliptin and metformin hydrochloride modified-release tablets |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 100MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2022-04-11 |
| Actual start date | |
| Estimated end date | 2022-04-15 |
| Actual end date | 2022-04-11 |
| Shortage status | Resolved |
| Updated date | 2022-04-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-03-25 | English | Compare |
| v2 | 2022-03-25 | French | Compare |
| v3 | 2022-04-11 | English | Compare |
| v4 | 2022-04-11 | French | Compare |
| v5 | 2022-04-12 | English | Compare |
Showing 1 to 5 of 5